顺逆结合肝门显露法治疗侵犯肝门的肝内胆管细胞癌

Combined anterograde and retrograde method exposing porta hepatis for the treatment of intrahepatic cholangiocarcinoma invading porta hepatis

  • 摘要: 目的:探讨顺逆结合肝门显露法治疗侵犯肝门的肝内胆管细胞癌的手术安全性和临床疗效。
    方法:采用回顾性描述性研究方法。收集2015年2月至2016年5月上海交通大学医学院附属仁济医院收治的3例左侧肝内胆管细胞癌侵犯肝门患者的临床病理资料。3例患者术前均经实验室和影像学检查,肝功能和剩余肝脏体积评估后,施行左半肝联合肝尾状叶切除术,手术操作步骤为顺行解剖肝门、敞开肝门板、左半肝联合肝尾状叶切除、肝右动脉重建、肝门胆管整形与胆肠吻合。 观察指标:(1)手术情况:手术时间,肝动脉吻合时间和术中出血量。(2)术后病理学检查结果。(3)术后情况:术后并发症(胆汁漏、出血、肝功能异常、胃瘫等)和术后化疗。(4)随访情况:患者术后生存和肿瘤复发情况。采用门诊方式进行随访,随访内容包括:患者临床症状腹痛、畏寒、发热、黄染等状况,肝功能和肿瘤标志物检查,彩色多普勒超声或腹部增强CT检查判断肿瘤有无复发。随访时间截至2016年12月。计量资料以平均数(范围)表示。
    结果:(1)手术情况:3例患者均采用顺逆结合肝门显露法行左半肝联合肝尾状叶切除术,其中1例合并肝右动脉切除重建,手术均顺利完成,无围术期死亡患者。3例患者平均手术时间为493 min (430~570 min),肝动脉吻合时间为11 min,术中平均出血量为526 mL(450~600 mL)。(2)术后病理学检查结果显示:3例患者均为肝内胆管细胞癌,2例侵犯神经束,2例第12组淋巴结转移,胆管和肝动脉切缘均为阴性。(3)术后情况:3例患者术后均未发生胆汁漏和胃瘫。1例行肝右动脉切除重建患者术后肝功能不全,经抗感染、保肝和抗肝性脑病治疗后,于术后4周恢复出院。另2例患者术后恢复平稳,未出现肝功能不全等并发症,分别在术后17 d和20 d出院。3例患者术后4~5周起采用吉西他滨联合替吉奥化疗方案,共化疗8个疗程。(4)随访情况:3例患者均获得随访,随访时间为7~20个月,随访期间患者一般状况均良好,无胆管炎症状,肝功能正常。1例患者重建肝右动脉,术后3个月复查CT,肝动脉显影良好。 3例患者均无肿瘤复发征象。
    结论:顺逆结合肝门显露法治疗侵犯肝门的肝内胆管细胞癌可提高其根治性切除率和手术安全性。

     

    Abstract: Objective:To explore the surgical safety and clinical efficacy of combined anterograde and retrograde method exposing porta hepatis for the treatment of the intrahepatic cholangiocarcinoma invading porta hepatis.
    Methods:The retrospective descriptive study was conducted. The clinicopathological data of 3 patients with left intrahepatic cholangiocarcinoma invading porta hepatis who were admitted to the Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine from February 2015 to May 2016 was collected. All the 3 patients underwent left hemihepatectomy combined with caudate lobectomy after preoperative lab and imaging examinations and the evaluations of liver function and residual liver volume. The surgical procedures followed as: anterograde dissection of porta hepatis, exposure of hilar plate, left hemihepatectomy combined with caudate lobectomy, right artery resection and reconstruction, hilar cholangioplasty and bilioenteric anastomosis. Observation indicators included: (1) surgical situations: operation time, time of hepatic artery anastomosis and volume of intraoperative blood loss; (2) postoperative pathological examinations; (3) postoperative situations: postoperative complications (biliary fistula, hemorrhage, abnormal liver function, gastroplegia) and postoperative chemotherapy; (4) followup: postoperative patients′ survival and carcinoma occurrence. Followup was performed to by outpatient examination up to December 2016. The followup included clinical symptoms such as abdominal pain, chills, fever and jaundice, liver function and tumor marker examination, and color ultrasound Doppler or abdominal enhanced computed tomography (CT) was performed to detect carcinoma recurrence. Measurement data was represented as average (range).
    Results:(1) Surgical situations: all the 3 patients underwent successful left hemihepatectomy combined with caudate lobectomy using combined antegrade and retrograde method exposing porta hepatis, including 1 combined with right hepatic artery resection and reconstruction, without perioperative death. The average operation time, average time of hepatic artery anastomosis and average volume of intraoperative blood loss of 3 patients were 493 minutes (range, 430-570 minutes), 11 minutes and 526 mL (range, 450-600 mL), respectively. (2) Postoperative pathological examination showed 3 patients were diagnosed with cholangiocarcinoma, 2 with nerve bundles invaded and 2 with No.12 lymph node metastasis, with negative margins of bile duct and hepatic artery. (3) Postoperative situations: 3 patients are not complicated with biliary fistula and gastroplegia. One patient with postoperative liver dysfunction after right artery resection and reconstruction underwent antiinfection, hepatoprotection and antihepatic encephalopathy therapies, and then was improved and discharged from hospital at 4 weeks postoperatively. The other 2 patients recovered steadily without complications such as hypohepatia, and then respectively discharged from hospital at 17 and 20 days postoperatively. All the 3 patients underwent chemotherapy of gemcitabine combined with S1 for 8 courses at week 4 or 5 postoperatively. (4) Followup: all the 3 patients were followed up for 7-20 months, with good general conditions and normal liver function and without cholangitis symptoms. One patient received right artery reconstruction, and CT reexamination at postoperative month 3 showed fine imaging of right hepatic artery. There was no sign of carcinoma recurrence.
    Conclusion:The combined anterograde and retrograde method exposing porta hepatis for the treatment of the intrahepatic cholangiocarcinoma invading porta hepatis can increase the radical resection rate and surgical safety.

     

/

返回文章
返回